Results of a study that looked at more than 21,000 COVID-19 exposures among Minnesota healthcare workers showed that 25% were high-risk exposures in which the healthcare provider was within 6 feet of an infected patient for more than 15…

An ongoing trial of the antibody bamlanivimab—administered with remdesivir, an antiviral medication—on hospitalized COVID-19 patients has been halted by bamlanivimab’s manufacturer Eli Lilly. The decision was made to stop the trial after…

Even though they are at high risk of complications related to COVID-19, older adults are happier than younger people as the global pandemic continues on. The study, based out of Stanford University in Stanford, California, included 1,000…

Phase 3 General Distribution Funding from the United States Department of Health and Human Services Provider Relief Fund is available to dental practices. Opening on October 5 and closing November 6, the funding is part of the Coronavirus…

Two peer-reviewed studies demonstrate a decrease in deaths among hospitalized patients with COVID-19 across the board, including older adults and those with comorbidities. One study looked at 5,000 hospitalized COVID-19 patients in New York…

A University of Michigan School of Dentistry survey found that oral health professionals are less afraid of COVID-19 than other healthcare providers and non-healthcare providers, even though their work is noted as high risk. The survey of…

A survey of European experts in oral and maxillofacial surgery found that 80% noted aerosol-generating procedures in the dental setting as high risk in the transmission of the novel coronavirus. More than 80% asserted that face protection…

The U.S. Food and Drug Administration (FDA) has approved the antiviral drug remdesivir (brand name Veklury, Gilead Sciences) for treating patients hospitalized with COVID-19. This is the first treatment for COVID-19 to receive FDA approval.…

The United States Centers for Disease Control and Prevention (CDC) changed the definition of “close contact,” from spending 15 minutes consecutively within 6 feet of a person infected with the novel coronavirus to a total of 15…

The Institute for Health Metrics and Evaluation at the University of Washington School of Medicine in Seattle suggests that COVID-19 deaths may increase 78% by February 1, with a projected death toll of 390,000 Americans. The statisticians…